Search Labs

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Core Facilities >

Christopher Lu Lab

We use in vivo models of ischemic acute kidney injury in mice, and in vitro model systems to perform detailed studies of proinflammatory genes activated by renal ischemia/reperfusion.

  • Christopher Lu, M.D.
Acute kidney injury transplant rejection chronic kidney disease

Chung Lab

Chung Lab uses primary human specimens, patient-derived xenograft models, and genetically engineered mouse models to study the molecular mechanisms underlying disease stem cell function in hematologic malignancies.

  • Stephen Chung, M.D.
Cancer Biology

Cleaver Lab

Our lab focuses on the molecular and cellular mechanisms underlying cell fate specification during blood vessel development and organogenesis.

  • Ondine Cleaver, Ph.D.
Genetics, Development and Disease

CMRU - Cardiometabolic Research Unit

The discovery of ANP many years ago sparked interest in the use of natriuretic peptides to diagnose and treat heart failure and other salt-retaining disorders. Since then, there have been successes and failures. A more comprehensive understanding of the natriuretic peptide system, including the role of noncardiac factors such as race/ethnicity, may encourage more targeted approaches. One of the original insights of de Bold et al, was that the heart is an endocrine organ. Endocrine therapies are administered to individuals with specific evidence of endocrine dysfunction, not to capture short-term beneficial effects. For instance, thyroid hormone is given only to patients in whom hypothyroidism is demonstrated, not based on its metabolic actions. Studies are warranted to determine whether a similar strategy for the heart’s endocrine system can advance the prevention and treatment of cardiometabolic disease. CMRU is strategically positioned to advance research toward this important strategic goal. 

  • Thomas Wang, M.D.
  • Ambarish Pandey, M.D.

Cobanoglu Lab

Both we (Cobanoglu et al., 2013) and others (Murphy, 2011) have reported that active machine learning driven experimentation can increase efficiency in the drug discovery process in the preclinical stage. We have a view towards integrating our computational work with an experimental pipeline. That is exactly why we are housed in a biomedical powerhouse, the UT Southwestern Medical Center, to execute this vision.

  • Murat Can Çobanoğlu, Ph.D.

Cobb Lab

The Cobb lab studies signal transduction mechanisms of protein kinases and how kinase structures lead to cell biological functions. We are particularly focused on the contributions of ERK MAP kinases to pancreatic beta-cell function and to lung cancers, and on the cell biological actions of WNK protein kinases.

  • Melanie Cobb, Ph.D.
Cancer Biology Cell and Molecular Biology

Collins Lab

We believe that understanding the basic biology of the schistosomes is key to developing the next generation of anti-schistosome drugs and vaccines. We also contend that by studying the basic biology of these fascinating organisms, we can better understand important basic biological processes common to all animals, including humans. For that reason, we study schistosomes from multiple angles using a variety of modern molecular approaches.of the lab. 

  • James J. Collins III, Ph.D.
Cell and Molecular Biology Genetics, Development and Disease

Cong Lab

We mine large-scale data for biological discoveries.

  • Qian Cong, Ph.D.

Conrad Lab

RNA Biology Meets Herpes Virology

  • Nicholas K. Conrad, Ph.D.
Biological Chemistry Molecular Microbiology

Conzen Lab

 In prior work, my laboratory focused on identifying novel mechanisms of therapy-resistance and progression in breast, prostate and ovarian cancer. 

  • Suzanne D. Conzen, M.D.
Cancer Biology

Corbin Lab

The research focus in the Corbin lab investigates strategies that exploits the deviant metabolism of cancer cells (namely the reprogramming of lipid metabolism and altered redox biology) for therapeutic purposes.

  • Ian Corbin, Ph.D.
Biomedical Engineering Cancer Biology

Corey Lab

Corey Lab is using nucleic acids or nucleic acid mimics to explore important cellular processes, develop novel therapeutic tools and strategies.

  • David R. Corey, Ph.D.
Nucleic Acids
Biological Chemistry Molecular Biophysics

Cotter Research Group

The Cotter Research Group is a clinical lab focused on strategies to improve outcomes for patients with liver diseases with a particular focus on alcohol and metabolic dysfunction-associated liver diseases.

  • Thomas Cotter, M.D.

Cowell Lab

Dr. Cowell has built a research program focused on the development of bioinformatics and computational biology methods for studying the immune system and infectious diseases.  

  • Lindsay Cowell, Ph.D.
Cancer Biology Immunology

D'Orso Lab

D'Orso Lab studies gene regulatory networks in normal and disease states as well as in the context of host-pathogen interactions.

  • Ivan D'Orso, Ph.D.
HIV-1 AIDS Host-Pathogen Cancer Gene regulation Transcription Chromatin Epigenetics
Biological Chemistry Molecular Microbiology

Danuser Lab

The Danuser lab develops computer vision methods and mathematical models in combination with live cell imaging approaches to unveil non-genetic mechanisms of cancer metastasis and drug resistance.
Specialty areas: Computer Vision, Computational Biology, Live Cell Imaging

  • Gaudenz Danuser, Ph.D.
  • Jungsik Noh, Ph.D.
Biomedical Engineering Cancer Biology

Data Science Shared Resource

We work with you on data management and process, database and web application, experimental design and grant support.

  • Jeon Lee, Ph.D.
Biomedical Engineering

Dauer Lab

The central goal of the Dauer Lab is to unravel the molecular and cellular mechanisms of diseases that disrupt the motor system. In exploring these diseases, we also aim to understand a fundamental question relevant to CNS disease generally: what factors determine the selective vulnerability of particular cell types or circuits to insults? Our primary focus is on Parkinson’s disease and inherited forms of dystonia. We focus our efforts on disease genes that cause these disorders, employing a range of molecular, cellular, and whole animal studies to dissect the normal role of disease proteins, and how pathogenic mutations lead to disease.

  • William Dauer, M.D.
parkinson's disease central nervous system disease Dystonia

Davenport Lab

The Davenport Lab is a branch of the ANSIR Lab at UTSW that focuses on quantitative methods for human brain imaging, primarily using MRI and Magnetoencephalography (MEG).

  • Elizabeth Davenport, Ph.D.
brain alzheimer's disease concussion
Biomedical Engineering

Davis (Anthony) Lab

The Davis Lab is part of the Division of Molecular Radiation Oncology in the Department of Radiation Oncology

  • Anthony Davis, Ph.D.
DNA damage response
Cancer Biology Cell and Molecular Biology

De Brabander Lab

The De Brabander Lab focuses on the synthesis of complex molecular architectures, including both designed and naturally occurring substances with novel structural features and interesting biological function. 

  • Jef De Brabander, Ph.D.
Organic Chemistry

de Gracia Lux Lab

Check out the latest research efforts of de Gracia Lux's Lab!

  • Caroline de Gracia Lux, Ph.D.
Biomedical Engineering

Dean Lab

The Dean Lab aims to develop and apply cutting-edge microscopy instrumentation and analyses to gain insight into otherwise intractable biological problems.

  • Kevin M. Dean, Ph.D.